MCL1 and melanoma: In particular, the ability of dinaciclib to regulate these anti-apoptotic proteins is likely to be of great utility in melanoma where overexpression of XIAP [41], Bcl-2 [42] and Mcl-1 [43] is commonplace and can contribute to melanoma chemoresistance.